Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep;128(3):1393-400.
doi: 10.1378/chest.128.3.1393.

1-year pulmonary function and health status in survivors of severe acute respiratory syndrome

Kian-Chung Ong  1 , Alan Wei-Keong Ng, Lawrence Soon-U Lee, Gregory Kaw, Seow-Khee Kwek, Melvin Khee-Shing Leow, Arul Earnest
Affiliations

1-year pulmonary function and health status in survivors of severe acute respiratory syndrome

Kian-Chung Ong et al. Chest. 2005 Sep.

Abstract

Study objectives: To characterize the long-term pulmonary function and health status in a prospectively identified cohort of patients who survived the severe acute respiratory syndrome (SARS).

Design: Prospective follow-up cohort study.

Setting: University-affiliated hospital.

Patients: Ninety-four patients who recovered from SARS were assessed at a uniform time point of 1 year after hospital discharge.

Measurements: The study included the measurement of static and dynamic lung volumes, the determination of the diffusing capacity of the lung for carbon monoxide (D(LCO)), and a health status evaluation using the St. George Respiratory Questionnaire (SGRQ).

Results: Eleven patients (12%) had mild impairment of FVC, 20 (21%) had mild impairment of FEV1, 5 (5%) had mild impairment of the FEV1/FVC ratio, and 17 (18%) had mild impairment of the D(LCO). There was one patient (1%) who had moderate impairment of FVC, one patient (1%) who had moderate impairment of the FEV1/FVC ratio, and three patients (3%) who had moderate impairment of the D(LCO). No pulmonary function abnormalities were detected in 59 patients (63%). Mean scores were significantly higher (ie, worse) than the population norms in the activity (p < 0.001), impacts (p < 0.001), and total (p < 0.001) domains of the SGRQ.

Conclusions: One year after recovery from SARS, persistent pulmonary function impairment was found in about one third of patients. The health status of SARS survivors was also significantly worse compared with the healthy population. The main determinants of morbidity in recovered SARS patients need to be further defined.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Enrollment of patients and follow-up at 3 months after hospital discharge.
See this image and copyright information in PMC

Comment in

References

    1. Ksiazek TG, Erdman D, Goldsmith CS. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. - PubMed
    1. Rainer TH. Severe acute respiratory syndrome: clinical features, diagnosis, and management. Curr Opin Pulm Med. 2004;10:159–165. - PubMed
    1. Han Y, Geng H, Feng W. A follow-up study of 69 discharged SARS patients. J Tradit Chin Med. 2003;23:214–217. - PubMed
    1. Peng M, Cai BQ, Liu T. Assessment of pulmonary function in SARS patients during the convalescent period. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003;25:529–532. - PubMed
    1. Liu T, Peng M, Cai BQ. Assessment of health-related quality of life in cured SARS patient. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003;25:16–19. - PubMed

Publication types